Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Generic Labeling Reg Could Fuel Suits Against Brands As Well

Jan 14 2014

• By Brenda Sandburg

Related Content

J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision

Nov 05 2013

Wyeth Rapamune Off-Label Marketing Settlement Will Not Alter Pfizer’s CIA

Jul 31 2013

FDA Proposes Unilateral Generic Drug Label Changes, Signaling End To Liability Shield

Nov 09 2013

Related Companies

Wyeth

Johnson & Johnson

Johnson & Johnson

ISTA Pharmaceuticals, Inc.

Roche Holding AG

Takeda Pharmaceutical Co. Ltd.

Additional Topics

United States Legal Issues BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window